3.5. Analysis.
Comparison 3 Rivastigmine 20 cm2 patch (17.4 mg/day) versus placebo, Outcome 5 ADCS‐ADL (change from baseline at 24 weeks) ITT.
Comparison 3 Rivastigmine 20 cm2 patch (17.4 mg/day) versus placebo, Outcome 5 ADCS‐ADL (change from baseline at 24 weeks) ITT.